Belite Bio (BLTE) Other Gross PP&E Adjustments (2021 - 2025)

Belite Bio's (BLTE) quarterly Other Gross PP&E Adjustments came in at $103000.0 in Q4 2025, up 319.15% year-on-year from $24573.6 in Q4 2024, and up 120.24% quarter-over-quarter from -$509000.0 in Q3 2025.

Belite Bio (BLTE) Other Gross PP&E Adjustments (2021 - 2025) Analysis & Trends

Belite Bio's Other Gross PP&E Adjustments history runs 5 years deep, the most recent figure standing at $103000.0 for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 319.15% year-over-year to $103000.0 in Q4 2025; TTM through Dec 2025 was $103000.0, a 319.15% increase from a year earlier, with the FY2025 full-year figure at $103000.0, up 319.15% from the prior year.
  • Other Gross PP&E Adjustments climbed to $103000.0 in Q4 2025 per BLTE's latest filing, from -$509000.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $141000.0 in Q4 2021 and bottomed at -$624000.0 in Q4 2023.
  • The 5-year median for Other Gross PP&E Adjustments is -$278000.0 (2024), against an average of -$259166.7.
  • Across the five-year window, Other Gross PP&E Adjustments plunged 539.01% in 2022 and jumped 319.15% in 2025, its largest moves.
  • Year by year, Other Gross PP&E Adjustments stood at $141000.0 in 2021, then plunged by 539.01% to -$619000.0 in 2022, then dropped by 0.81% to -$624000.0 in 2023, then surged by 92.47% to -$47000.0 in 2024, then soared by 319.15% to $103000.0 in 2025.
  • Per Business Quant, the three latest BLTE Other Gross PP&E Adjustments figures stand at $103000.0 (Q4 2025), -$509000.0 (Q3 2025), and -$47000.0 (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -3.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 35.73 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -1.69 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -67.74 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -189.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 103,000.00
Dec 31, 2025 103,000.00
Sep 30, 2025 -509,000.00
Sep 30, 2025 -509,000.00
Dec 31, 2024 -47,000.00
Dec 31, 2024 -47,000.00
Dec 31, 2023 -624,000.00
Dec 31, 2023 -624,000.00
Dec 31, 2022 -619,000.00
Dec 31, 2022 -619,000.00
Dec 31, 2021 141,000.00
Dec 31, 2021 141,000.00